ST-CLAUD, France, September 4, 2018 /PRNewswire/ --

Emmanuel SCHMIDT has been appointed Chief Financial Officer and Senior Vice President of Ethypharm Group. He reports to Hugues Lecat President and Chief Executive Officer and joins the Executive Committee.

     (Logo: https://mma.prnewswire.com/media/708212/Ethypharm_Logo.jpg )

     (Photo: https://mma.prnewswire.com/media/738901/Emmanuel_SCHMIDT_Ethypharm.jpg )

Emmanuel SCHMIDT, 49, holds a Master of Science in Business Management of EDHEC Lille. With twenty years' experience serving as CFO for major international groups, Emmanuel has a 360° vision of his function. Having spent 8 years as CFO of Pierre Fabre Pharma division, he possesses an in-depth knowledge of the pharmaceutical industry and also has a great command of the LBO mechanisms acquired at Elior and Star's Service. Since 2010, Emmanuel worked as the CFO of the Star's Service Group.

"I am very pleased to welcome Emmanuel as Ethypharm's new Chief Financial Officer," said Hugues Lecat. "Emmanuel's deep knowledge of the pharmaceutical industry as well as his financial acumen make him highly qualified to take on the CFO role. Emmanuel is a perfect addition to the executive team to foster the growth of Ethypharm and pursue its Transformation."

About Ethypharm 

Ethypharm is a European-based specialty pharmaceutical company with global reach and a committed player in the treatment of pain and addiction.

Ethypharm also develops and markets complex generics and essential medicines that help reduce healthcare costs, particularly in the field of emergency care and oncology.

The Company employs 1400 people mainly in Europe, and its drugs are marketed in more than 80 countries.

Our ambition is to become the European leader for the treatment of pain and addiction, and to help patients around the world gain access to high quality, essential and affordable medicines.

To learn more about the Ethypharm Group, visit our website: http://www.ethypharm.com

Press contact - Avril Ponnelle, presse@ethypharm.com , + 33-(0)-1-41-12-17-20

SOURCE Ethypharm